⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Adimab Collaborator GSK Receives Additional Marketing Approval for Depemokimab
prnewswire.com
GSK
BIIB
LLY
MRK
TAK
ALNY
BMY
NVS
REGN
VRTX
What if you could reboot sick cells?
globenewswire.com
NVS
Peoria Community Unites at 2026 Susan G. Komen ® MORE THAN PINK Walk
businesswire.com
BAC
NTRA
GH
NVS
LLY
CAT
Orlando Community Unites at 2026 Susan G. Komen ® MORE THAN PINK Walk
businesswire.com
BAC
NTRA
GH
NVS
LLY
Dyslexia Treatment Market Report 2026: $40+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
PFE
AZN
NVS
B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Report 2026 - Worth $18.75 Billion in 2026, the Market is Expected to Reach $44.29 Billion by 2030
globenewswire.com
JNJ
AZN
BMY
NVS
GSK
AMGN
Frontier Medicines Appoints Veteran Drug Development Leader David R. Epstein to Board of Directors
businesswire.com
PFE
NVS
RNA Therapies Market Research and Competitive Landscape Report 2026
globenewswire.com
NVS
ARWR
ALNY
Oligonucleotides Market Research and Competitive Landscape Report 2026 Featuring Novartis, Astellas, Alnylam Pharmaceuticals, Ionis Pharmaceuticals
globenewswire.com
NVS
ALNY
IONS
BRAF Mutated Non-small Cell Lung Cancer (NSCLC) Market Insight, Epidemiology, and Market Forecast Report 2022-2026 & 2026-2036 Featuring Novartis, Genentech, Fore Biotherapeutic, and C4 Therapeutics
globenewswire.com
NVS
CGNX
FBIO
CTXR